Joerg Gruber
Fondatore presso Clubb Capital Ltd.
Profilo
Joerg Gruber is the founder of DMS Data Systems LLC (founded in 2006), Clubb Capital Ltd.
(founded in 1995), Pathfinder LLC (founded in 2008), Tarix Pharmaceuticals Ltd.
(founded in 2007), and Pathfinder Cell Therapy, Inc. (founded in 2011).
Mr. Gruber is also the founder of Constant Therapeutics LLC.
Mr. Gruber's current job(s) include being the Chairman of Tarix Orphan LLC, a Non-Executive Director at Metriopharm AG (since 2018), and a Director at Formation Biologics Corp.Mr. Gruber's former job(s) include being an Independent Director at SyntheMed, Inc. (from 2007 to 2011), Director-Fixed Income Sales at Shearson Lehman Bros., Inc. (from 1988 to 1990), Director at Scandinavian Minerals Ltd.
(from 2006 to 2008), and Director at Bristol-Myers Squibb FCT bêta, Inc. (from 2012 to 2020).
Posizioni attive di Joerg Gruber
| Società | Posizione | Inizio |
|---|---|---|
| Clubb Capital Ltd. | Fondatore | 23/09/2011 |
Tarix Pharmaceuticals Ltd.
 Tarix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Tarix Pharmaceuticals Ltd. develops peptide drugs. The private company is based in Brookline, MA. The company was founded by Joerg Gruber, Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | Fondatore | 01/01/2007 |
Tarix Orphan LLC
 Tarix Orphan LLC Pharmaceuticals: MajorHealth Technology Tarix Orphan LLC is a pharmaceutical company that manufactures pharmaceutical formulation products. The private company is based in Cambridge, MA. The company was founded by Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | Presidente | - |
Metriopharm AG
 Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | Direttore/Membro del Consiglio | 20/06/2018 |
Formation Biologics Corp.
 Formation Biologics Corp. Miscellaneous Commercial ServicesCommercial Services Formation Biologics Corp. operates as a biopharmaceutical drug development company. It discovers and develops drugs and medicines for treatment of patients with cancers and orphan diseases. The company was founded in 2011 and is headquartered in Austin, TX. | Direttore/Membro del Consiglio | - |
| Constant Therapeutics LLC | Fondatore | - |
Precedenti posizioni note di Joerg Gruber
| Società | Posizione | Fine |
|---|---|---|
Bristol-Myers Squibb FCT bêta, Inc.
 Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Direttore/Membro del Consiglio | 21/09/2020 |
SyntheMed, Inc.
 SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Direttore/Membro del Consiglio | 16/09/2011 |
| Pathfinder LLC | Fondatore | 16/09/2011 |
| ░░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PATHFINDER CELL THERAPY, INC. | Health Technology |
| Aziende private | 12 |
|---|---|
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Health Technology |
Shearson Lehman Bros., Inc.
 Shearson Lehman Bros., Inc. Investment Banks/BrokersFinance Part of Lehman Brothers Holdings, Inc., Shearson Lehman Bros., Inc. provides security broker services. The company is based in New York, NY. | Finance |
Scandinavian Minerals Ltd.
 Scandinavian Minerals Ltd. Other Metals/MineralsNon-Energy Minerals Scandinavian Minerals Ltd. explores for copper and nickel. The company is based in Toronto, Canada and has subsidiaries in Finland and Sweden. Scandinavian Minerals was acquired by First Quantum Minerals Ltd. on June 18, 2008 for $258.21 million. The Canadian company was founded in 2003 by Peter Donald Walker. | Non-Energy Minerals |
DMS Data Systems LLC
 DMS Data Systems LLC Miscellaneous Commercial ServicesCommercial Services DMS Data Systems is an information company focused on providing data resources to companies and organizations around the globe that work in the biomedical industry and related fields. DMS products and services include the development of online subscription databases, website content monitoring, and data feeds. The DMS Data Center database provides flexible, time saving methods for identifying, monitoring, and capturing critical industry information to make more informed business decisions. | Commercial Services |
Metriopharm AG
Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | Health Technology |
| Clubb Capital Ltd. | |
| Pathfinder LLC | Health Technology |
Tarix Pharmaceuticals Ltd.
Tarix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Tarix Pharmaceuticals Ltd. develops peptide drugs. The private company is based in Brookline, MA. The company was founded by Joerg Gruber, Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | Health Technology |
Tarix Orphan LLC
Tarix Orphan LLC Pharmaceuticals: MajorHealth Technology Tarix Orphan LLC is a pharmaceutical company that manufactures pharmaceutical formulation products. The private company is based in Cambridge, MA. The company was founded by Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | Health Technology |
Formation Biologics Corp.
Formation Biologics Corp. Miscellaneous Commercial ServicesCommercial Services Formation Biologics Corp. operates as a biopharmaceutical drug development company. It discovers and develops drugs and medicines for treatment of patients with cancers and orphan diseases. The company was founded in 2011 and is headquartered in Austin, TX. | Commercial Services |
| Constant Therapeutics LLC | |
Bristol-Myers Squibb FCT bêta, Inc.
Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- Joerg Gruber
